Skip to main content
MedPathMedPath Home
Clinical Trials/2023-506227-29-00
2023-506227-29-00
Recruiting
Phase 1

A Phase 1 Open-Label Study to Evaluate the Efficacy and Safety of ABBV-400 in Select Advanced Solid Tumor Indications

AbbVie Deutschland GmbH & Co. KG15 sites in 2 countries60 target enrollmentJuly 29, 2024
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
AbbVie Deutschland GmbH & Co. KG
Enrollment
60
Locations
15
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
euclinicaltrials.eu
Start Date
July 29, 2024
End Date
TBD
Last Updated
last year

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Global Clinical Trials Helpdesk

Scientific

AbbVie Deutschland GmbH & Co. KG

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Study Sites (15)

Loading locations...

Similar Trials

Recruiting
Phase 1
A Phase 1b, Randomized, Open-Label Trial to Evaluate Safety, Engraftment, and Initial Signs of Clinical Activity of MB097 in Combination with Pembrolizumab in Melanoma Patients with Primary Resistance to an Anti-PD-1-Containing Immunotherapy (MELODY-1)
2023-507377-17-00Microbiotica Limited27
Not yet recruiting
Phase 1
A Phase 1a/1b, Open-Label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of BG-75098 Alone and in Combination With Other Agents in Patients With Advanced Solid Tumors
2025-523165-19-00BeOne Medicines I GmbH15
Not yet recruiting
Phase 1
Phase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and preliminary activity of [177Lu]Lu-NNS309 in patients with pancreatic, lung, breast and colorectal cancers.
2023-510356-23-00Novartis Pharma AG76
Completed
Phase 1
A Phase 1 Randomized Study to Evaluate the Effect of Food on the Bioavailability of BMS-986158 in Participants with Advanced Solid Tumors.
2023-506661-65-00Bristol-Myers Squibb Services Unlimited Company40
Recruiting
Phase 1
An open-label, randomized, single-dose, three-way crossover trial to evaluate the pharmacokinetics of nicotine pouch (NP) dry 4 mg compared with Nicorette® lozenge 4 mg in healthy adults who use cigarettes
2025-523879-34-00Swedish Match North Europe AB72